EUVIMEDEUVIMED entdecken
Crossref

Can optical evaluation distinguish between T1a and T1b esophageal adenocarcinoma: an international expert interobserver agreement study

Sunil Gupta iD, Francesco Vito Mandarino iD, Neal Shahidi iD, Luke F Hourigan, Helmut Messmann, Michael B Wallace iD, Alessandro Repici, Mario Dinis-Ribeiro, Gregory B Haber, Andrew C F Taylor, Irving Waxman, Peter D Siersema und 14 weitere

Endoscopy · 01.03.2025 · 57 (03) · 200-207

DOI: 10.1055/a-2399-1401 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.03.2025. Verfasst von Sunil Gupta und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Westmead Hospital, Sydney, Australia. Hauptthemen laut MEDLINE: Adenocarcinoma, Barrett Esophagus, Esophagoscopy, Observer Variation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Piecemeal endoscopic mucosal resection (EMR) is an acceptable technique for T1a esophageal adenocarcinoma, but en bloc R0 excision is advocated for T1b disease as it may offer a potential cure and mitigate recurrence. Thus, distinguishing between T1a and T1b disease is imperative under current treatment paradigms. We investigated whether expert Barrett’s endoscopists could make this distinction based on optical evaluation.

Methods

Endoscopic images of histologically confirmed high grade dysplasia (HGD), T1a, and T1b disease (20 sets for each) were compiled from consecutive patients at a single institution. Each set contained four images including an overview, a close-up in high definition white light, a near-focus magnification image, and a narrow-band image. Experts predicted the histology for each set.

Results

19 experts from 8 countries (Australia, USA, Italy, Netherlands, Germany, Canada, Belgium, and Portugal) participated. The majority had been practicing for > 20 years, with a median (interquartile range) annual case volume of 50 (18–75) for Barrett’s EMR and 25 (10–45) for Barrett’s endoscopic submucosal dissection. Esophageal adenocarcinoma (T1a/b) could be distinguished from HGD with a pooled sensitivity of 89.1 % (95 %CI 84.7–93.4). T1b adenocarcinoma could be predicted with a pooled sensitivity of 43.8 % (95 %CI 29.9–57.7). Fleiss’ kappa was 0.421 (95 %CI 0.399–0.442; P < 0.001), indicating fair-to-moderate agreement.

Conclusions

Expert Barrett’s endoscopists could reliably differentiate T1a/T1b esophageal adenocarcinoma from HGD. Despite fair-to-moderate agreement for T staging, T1b disease could not be reliably distinguished from T1a disease. This may impact clinical decision making and selection of endoscopic techniques.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenocarcinomaBarrett EsophagusEsophagoscopyObserver VariationAgedFemaleHumansMaleMiddle AgedDiagnosis, DifferentialEndoscopic Mucosal ResectionEsophageal NeoplasmsNarrow Band ImagingNeoplasm StagingSensitivity and Specificity

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Westmead Hospital, Sydney, Australia.
  • Westmead Clinical School, University of Sydney, Sydney, Australia.
  • Princess Alexandra Hospital, Woolloongabba, Australia.
  • Department of Gastroenterology and Infectious Diseases, University Hospital, Augsburg, Germany.
  • Mayo Clinic, Jacksonville, Florida, United States.
  • Endoscopy Unit, Humanitas Clinical and Research Center - IRCCS, Rozzano, Italy.

ORCID-Profile: Sunil Gupta, Francesco Vito Mandarino, Neal Shahidi, Michael B Wallace, Raf Bisschops, Torsten Beyna, Nicholas G Burgess

Zitieren

APA

Gupta, S., Mandarino, F. V., Shahidi, N., Hourigan, L. F., Messmann, H., Wallace, M. B., Repici, A., Dinis-Ribeiro, M., Haber, G. B., Taylor, A. C. F., Waxman, I., Siersema, P. D., Pouw, R. E., Lemmers, A., Bisschops, R., Mosko, J. D., Teshima, C., Ragunath, K., Rösch, T., …, & study working group (2025). Can optical evaluation distinguish between T1a and T1b esophageal adenocarcinoma: an international expert interobserver agreement study. Endoscopy, 57(03), 200-207. https://doi.org/10.1055/a-2399-1401

Vancouver

Gupta S, Mandarino FV, Shahidi N, Hourigan LF, Messmann H, Wallace MB, et al. Can optical evaluation distinguish between T1a and T1b esophageal adenocarcinoma: an international expert interobserver agreement study. Endoscopy. 2025;57(03):200-207. doi:10.1055/a-2399-1401

BibTeX
@article{Gupta2025,
  author = {Gupta, Sunil and Mandarino, Francesco Vito and Shahidi, Neal and Hourigan, Luke F and Messmann, Helmut and Wallace, Michael B and Repici, Alessandro and Dinis-Ribeiro, Mario and Haber, Gregory B and Taylor, Andrew C F and Waxman, Irving and Siersema, Peter D and Pouw, Roos E and Lemmers, Arnaud and Bisschops, Raf and Mosko, Jeffrey D and Teshima, Christopher and Ragunath, Krish and Rösch, Thomas and Pech, Oliver and Beyna, Torsten and Sharma, Prateek and Lee, Eric Y T and Burgess, Nicholas G and Bourke, Michael J and study working group, study working group},
  title = {Can optical evaluation distinguish between T1a and T1b esophageal adenocarcinoma: an international expert interobserver agreement study},
  journal = {Endoscopy},
  year = {2025},
  volume = {57},
  number = {03},
  pages = {200--207},
  doi = {10.1055/a-2399-1401}
}
Kostenlos starten →